Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More…
Stem Cells Template
Write in a clean editor, then format for Stem Cells in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Stem Cells format
Stem Cells is a peer-reviewed journal published by Oxford University Press, covering Pluripotent Stem Cells Research, Mesenchymal stem cell research, Hematopoietic Stem Cell Transplantation.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Stem Cells, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — Stem Cells has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Pluripotent Stem Cells Research Mesenchymal stem cell research Hematopoietic Stem Cell Transplantation CRISPR and Genetic Engineering Neurogenesis and neuroplasticity mechanisms |
| ISSN | 1066-5099 |
| Citation impact (2-yr) | 3.37 |
| h-index | 286 |
| i10-index | 4,918 |
| Total citations | 476,942 |
| Article processing charge | $4,140 |
| Top institutions publishing here | Inserm |
| Journal website | academic.oup.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Stem Cells per year
Citation impact of Stem Cells by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Stem Cells
MSCs are nonhematopoietic stromal cells that are capable of differentiating into, and contribute to the regeneration of, mesenchymal tissues such as bone, cartilage, muscle, ligament, tendon, and adipose. MSCs are rare in bone marrow, representing approximately 1 in 10,000 nucleated cells. Although not immortal, they have the ability to expand manyfold in culture while retaining…
Bone marrow stromal cells are progenitors of skeletal tissue components such as bone, cartilage, the hematopoiesis-supporting stroma, and adipocytes. In addition, they may be experimentally induced to undergo unorthodox differentiation, possibly forming neural and myogenic cells. As such, they represent an important paradigm of post-natal nonhematopoietic stem cells, and an easy source for potential therapeutic…
Mesenchymal stem cells or multipotent stromal cells (MSCs) isolated from the bone marrow of adult organisms were initially characterized as plastic adherent, fibroblastoid cells with the capacity to generate heterotopic osseous tissue when transplanted in vivo. In recent years, MSCs or MSC-like cells have been shown to reside within the connective tissue of most organs,…
Mesenchymal stem cell transplantation is undergoing extensive evaluation as a cellular therapy in human clinical trials. Because MSCs are easily isolated and amenable to culture expansion in vitro there is a natural desire to test MSCs in many diverse clinical indications. This is exemplified by the rapidly expanding literature base that includes many in vivo…